Eli Lilly shares have underperformed the broader market over the past year, but Wall Street analysts remain firmly bullish in ...

London (UKX:IND) +0.17% to 9,158 but lagged other European indexes. Germany (DAX:IND) +0.52% to 23,971, marking thrid day of gains backed by upbeat corporate eanings. German factory orders ...

Revenue at the unit, which houses AMD’s all-important artificial intelligence chips that are viewed as central to the company ...

Novo Nordisk (NVO) said Wednesday it will cut costs as it faces increasing competition from Eli Lilly (LLY) and generic ...

India's Divi's Laboratories reported first-quarter profit below estimates on Wednesday, as manufacturers producing generic ...

Novo Nordisk is to cut costs as the Wegovy-maker battles competition from rival Eli Lilly and copycat versions of its obesity ...

Eli Lilly and Company is gearing up for its second quarter earnings report this Thursday, before the market opens. The pharmaceutical giant has witnessed significant revenue boosts from its ...

Global pharmaceutical company Eli Lilly (NYSE:LLY) will be reporting earnings this Thursday before the bell. Here’s what ...

Eli Lilly's stock is lagging the S&P 500 since April, potentially allowing a catch-up trade if results impress. Medicare may ...

Under the terms of the agreement, Eli Lilly is to make double-digit million-dollar upfront payments and invest in LTZ’s equity. In addition, LTZ is entitled to receive preclinical, clinical, ...

Novo Nordisk (NYSE: NVO) stock is testing the patience of buy-and-hold investors. Over the last five years, NVO stock is up more than 200%. However, in the last year, it’s down over 61% and more than ...

Hims & Hers Health stock fell as much as 5% early Tuesday after the company reported revenue late Monday that fell shy of ...